Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06579950Not ApplicableRecruiting

Assessing the Effects of Cool Roofs on Indoor Environments and Health

Role: collaborator

NCT07229677Recruiting

Cohort Study of Arbovirus and Other Emerging Virus Infections in Fiji: AEVI-Fiji Cohort.

Role: lead

NCT05168410Completed

Sensitivity and Specificity of the Alvarado Score for the Timely Differential Diagnosis of Acute Appendicitis in Samoa

Role: collaborator

NCT05167292Completed

Aetiology, Management and Outcomes of Acute Kidney Injury in Samoa.

Role: collaborator

NCT02188862Completed

Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region

Role: collaborator

All 5 trials loaded